PL1815755T3 - Polepszanie integralności bariery jelitowej - Google Patents

Polepszanie integralności bariery jelitowej

Info

Publication number: PL1815755T3
Authority: PL; Poland
Prior art keywords: improvement; barrier integrity; intestinal barrier; mammal; acid
Prior art date: 2004-06-22

Application number

PL07108969T

Other languages

English (en)

Inventor

Tol Eric Alexander Franciscus Van

Linette Eustachia Maria Willemsen

Marleen Antoinette Koetsier

Christopher Beermann

Bernd Stahl

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-22

Filing date

2004-06-22

Publication date

2009-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34957849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1815755(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-22 Application filed by Nutricia Nv filed Critical Nutricia Nv

2009-09-30 Publication of PL1815755T3 publication Critical patent/PL1815755T3/pl

Links

210000005027 intestinal barrier Anatomy 0.000 title 1
230000007358 intestinal barrier function Effects 0.000 title 1
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 4
241000124008 Mammalia Species 0.000 abstract 2
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 2
235000021342 arachidonic acid Nutrition 0.000 abstract 2
229940114079 arachidonic acid Drugs 0.000 abstract 2
235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 2
229960005135 eicosapentaenoic acid Drugs 0.000 abstract 2
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 2
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 abstract 1
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 abstract 1
230000004888 barrier function Effects 0.000 abstract 1
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 abstract 1
229920001542 oligosaccharide Polymers 0.000 abstract 1
150000002482 oligosaccharides Chemical class 0.000 abstract 1
230000004936 stimulating effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pediatric Medicine (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Glass Compositions (AREA)
Medicines Containing Plant Substances (AREA)

PL07108969T 2004-06-22 2004-06-22 Polepszanie integralności bariery jelitowej PL1815755T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07108969A EP1815755B1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity
PCT/NL2004/000444 WO2005122790A1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity

Publications (1)

Publication Number	Publication Date
PL1815755T3 true PL1815755T3 (pl)	2009-09-30

Family

ID=34957849

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL09158304T PL2100520T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej
PL07108969T PL1815755T3 (pl)	2004-06-22	2004-06-22	Polepszanie integralności bariery jelitowej
PL04748674T PL1672987T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL09158304T PL2100520T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL04748674T PL1672987T3 (pl)	2004-06-22	2004-06-22	Poprawa integralności bariery jelitowej

Country Status (20)

Country	Link
US (4)	US8252769B2 (pl)
EP (3)	EP1815755B1 (pl)
JP (1)	JP4903695B2 (pl)
CN (1)	CN100589712C (pl)
AT (2)	ATE363213T1 (pl)
AU (1)	AU2004320743B2 (pl)
BR (1)	BRPI0418921A (pl)
CA (1)	CA2570205C (pl)
CY (1)	CY1109224T1 (pl)
DE (2)	DE602004020813D1 (pl)
DK (3)	DK2100520T3 (pl)
ES (3)	ES2285484T3 (pl)
NZ (1)	NZ552166A (pl)
PL (3)	PL2100520T3 (pl)
PT (3)	PT2100520E (pl)
RU (1)	RU2402240C2 (pl)
SI (1)	SI1815755T1 (pl)
UA (1)	UA81875C2 (pl)
WO (1)	WO2005122790A1 (pl)
ZA (1)	ZA200700138B (pl)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
EP1597978A1 (en) *	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en) *	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
CA2570208A1 (en) *	2004-06-22	2005-12-29	N.V. Nutricia	Improvement of barrier integrity in hiv patients
EP1721611A1 (en) *	2005-04-21	2006-11-15	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
EP1723951A1 (en) †	2005-04-21	2006-11-22	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
CA2537452C (en) *	2005-03-09	2013-12-24	Abbott Laboratories	Concentrated human milk fortifier liquid
EP1714660A1 (en) *	2005-04-21	2006-10-25	N.V. Nutricia	Uronic acid and probiotics
ATE471665T1 (de) *	2005-04-21	2010-07-15	Nutricia Nv	Nahrungsergänzungsmittel für hiv-patienten
EP1776877A1 (en) *	2005-10-21	2007-04-25	N.V. Nutricia	Method for stimulating the intestinal flora
WO2007058523A1 (en) *	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
EP1800675B1 (en)	2005-12-23	2011-05-18	N.V. Nutricia	Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
JP4771882B2 (ja) *	2006-07-21	2011-09-14	味の素ゼネラルフーヅ株式会社	糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
ES2525223T3 (es) *	2006-08-04	2014-12-19	Shs International Ltd.	Fórmula sin proteínas
EP1969952A1 (en) *	2007-03-07	2008-09-17	Friesland Brands B.V.	Allergen-free or dairy free LCPUFA powdered compositions and the use thereof in food products and especially infant formulas
WO2008153377A1 (en) *	2007-06-15	2008-12-18	N.V. Nutricia	Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
SI2190304T1 (sl) *	2007-09-17	2012-04-30	Nutricia Nv	Prehranska formulacija z visoko energijsko vsebnostjo
WO2009096772A1 (en) *	2008-02-01	2009-08-06	N.V. Nutricia	Composition for stimulating natural killer cell activity
EP2130440A1 (en) *	2008-06-06	2009-12-09	N.V. Nutricia	Inhibiting E. sakazakii growth
SI2285387T1 (sl)	2008-06-13	2016-02-29	N.V. Nutricia	Prehrana za preprečevanje infekcij
WO2010027259A1 (en) *	2008-09-02	2010-03-11	N.V. Nutricia	Nutritional compositions with coated lipid globules
WO2010068086A1 (en)	2008-12-11	2010-06-17	N.V. Nutricia	Nutritional compositions with large lipid globule size
JP5738180B2 (ja) *	2009-03-26	2015-06-17	味の素ゼネラルフーヅ株式会社	生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
WO2010109626A1 (ja)	2009-03-26	2010-09-30	味の素ゼネラルフーヅ株式会社	生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
WO2011060123A1 (en)	2009-11-12	2011-05-19	Nestec S.A.	Nutritional composition for promoting gut microbiota balance and health
WO2011115476A1 (en) *	2010-03-17	2011-09-22	N.V. Nutricia	Infant nutrition for improving fatty acid composition of brain membranes later in life
BR112012027427A2 (pt) *	2010-04-26	2015-09-15	Nestec Sa	composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral
JP2013535984A (ja) *	2010-08-24	2013-09-19	アボット・ラボラトリーズ	官能特性を改善した栄養製品
EP2488042B1 (en)	2010-11-02	2013-10-02	Abbott Laboratories	Stable concentrated liquid human milk fortifier
BR112013016606A2 (pt)	2010-12-31	2016-09-27	Abbott Lab	processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
CA2822219C (en)	2010-12-31	2020-12-29	Abbott Laboratories	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
WO2012177118A1 (en)	2011-06-22	2012-12-27	N.V. Nutricia	Method for reducing the occurrence of infection in young children
PH12014500185A1 (en)	2011-07-22	2019-10-11	Abbott Lab	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
HK1199607A1 (en)	2011-08-29	2015-07-10	Abbott Laboratories	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US20140286908A1 (en)	2011-10-18	2014-09-25	Nestec S.A.	Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
EP2928325A1 (en)	2012-12-10	2015-10-14	N.V. Nutricia	Nutritional composition with non digestible oligosaccharides
US9352020B2 (en) *	2013-03-15	2016-05-31	Mead Johnson Nutrition Company	Reducing proinflammatory response
ES2693519T3 (es)	2013-11-01	2018-12-12	N.V. Nutricia	Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
EP3079502A1 (en)	2013-11-04	2016-10-19	N.V. Nutricia	Fermented formula with non digestible oligosaccharides
US9815473B2 (en)	2014-01-30	2017-11-14	Ford Global Technologies, Llc	Manual transmission clutch control using driveline measurements
JP6959136B2 (ja) *	2015-01-23	2021-11-02	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	患者の示差的な栄養所要量の決定方法
WO2017064304A1 (en)	2015-10-15	2017-04-20	N.V. Nutricia	Infant formula with special lipid architecture for promoting healthy growth
CN105231461A (zh) *	2015-10-30	2016-01-13	中营康园（北京）科技有限公司	一种提高机体免疫力的营养组合物及其应用
ES2987545T3 (es)	2016-12-09	2024-11-15	Nutricia Nv	Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo
JP7136807B2 (ja)	2017-04-17	2022-09-13	ザ・ユニバーシティ・オブ・シカゴ	ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料
CN110832089A (zh)	2017-05-12	2020-02-21	赢创运营有限公司	用于检测动物中由产气荚膜梭菌诱导的疾病的方法
CN107198250B (zh) *	2017-05-23	2019-03-12	北京瑞千景科技发展有限公司	改善肠道微生态预防慢性病组合物和均衡营养食品及应用
CA3092472A1 (en) *	2018-03-02	2019-09-06	Evonik Operations Gmbh	In vitro method for detecting intestinal barrier failure in animals
CN109527123A (zh) *	2018-12-14	2019-03-29	大连大学	一种对慢性肠炎具有改善作用的调和油
CA3122457A1 (en)	2018-12-14	2020-06-18	Evonik Operations Gmbh	In vitro method for detecting avian intestinal dysbiosis
WO2020229690A1 (en)	2019-05-15	2020-11-19	N.V. Nutricia	Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
WO2020245313A1 (en)	2019-06-04	2020-12-10	N.V. Nutricia	Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
EP4151097A1 (en)	2019-06-04	2023-03-22	N.V. Nutricia	Nutritional composition comprising 2'fucosyllactose and dietary butyrate
PL437793A1 (pl) *	2021-05-07	2022-11-14	Uniwersytet Medyczny w Łodzi	Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
GB2608587B (en) *	2021-06-25	2025-01-01	Mjn Us Holdings Llc	Use of extensively hydrolysed protein
US20240277739A1 (en) *	2021-07-01	2024-08-22	N.V. Nutricia	Nutritonal compositions for gut barrier function
WO2025233459A1 (en)	2024-05-08	2025-11-13	N.V. Nutricia	Nutritional composition for preventing intestinal barrier disruption

Family Cites Families (132)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2981629A (en)	1960-04-05	1961-04-25	Lewis F Ginnette	Process of dehydrating foams
DE2033677A1 (de)	1970-07-07	1972-02-17	Deutsche Laevosan Gesellschaft C F Boehringer & Sohne GmbH & Co KG, Suddeutsche Zucker AG, 6800 Mannheim	Arzneimittel
US4237118A (en)	1972-03-06	1980-12-02	Howard Alan N	Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (pl)	1973-05-21	1981-10-29
JPS5263224A (en)	1975-11-20	1977-05-25	Asahi Chem Ind Co Ltd	Resin compositions for coating powder with low-temperature curing prop erty
JPS5342340A (en)	1976-09-29	1978-04-17	Shin Kobe Electric Machinery	Method of producing battery plate
DE2844861A1 (de)	1978-10-14	1980-04-30	Kerstein Pharma Hameln Gmbh	Diaetetisches lebensmittel zur oralen oder kuenstlichen ernaehrung und verfahren zu seiner herstellung
FR2490496A1 (fr)	1980-09-19	1982-03-26	Roussel Uclaf	Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en)	1982-06-25	1984-03-20	Societe D'assistance Technique Pour Produits Nestle S.A.	Foaming creamer and method of making same
CA1324529C (en)	1987-09-15	1993-11-23	Tatsuhiko Kan	Liquid food comprising polydextrose and oligosaccharides
DE3734962C1 (de)	1987-10-15	1989-01-05	Luitpold Werk Chem Pharm	Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
IE61565B1 (en)	1988-08-24	1994-11-16	Akzo Nv	Heparin fragments and fractions with anti-HIV action
JP2782443B2 (ja)	1988-12-26	1998-07-30	將純吉原	抗エイズウィルス剤
DE3901048A1 (de)	1989-01-14	1990-07-19	Chimicasa Gmbh	Antikachectikum
JP2779963B2 (ja)	1989-02-09	1998-07-23	株式会社林原生物化学研究所	ビフィズス菌増殖促進剤
JPH02286058A (ja)	1989-04-28	1990-11-26	Nippon Synthetic Chem Ind Co Ltd:The	整腸剤
ES2033193B1 (es)	1990-10-30	1994-01-16	Ganadera Union Ind Agro	Mezcla grasa para nutricion infantil y de adultos.
CA2101274C (en)	1991-01-24	1998-12-15	David J. Kyle	Microbial oil mixtures and uses thereof
FR2673812B1 (fr)	1991-03-13	1994-04-01	Roussel Uclaf	Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
GB9109125D0 (en)	1991-04-27	1991-06-12	Cerestar Holding Bv	Sweetening composition
IT1248060B (it)	1991-06-14	1995-01-05	Italfarmaco Spa	Eparine acilate come inibitori della replicazione di retrovirus
GB9116054D0 (en)	1991-07-24	1991-09-11	Efamol Holdings	Preparation of fatty acid medicaments
US5629023A (en)	1991-12-31	1997-05-13	Bland; Jeffrey S.	Medical food composition for metabolic detoxification
CA2110993C (en)	1992-04-10	2002-02-05	Akihisa Takaichi	Food composition for inhibiting the formation of an intestinal putrefactive product
CA2089607C (en)	1992-11-05	1997-11-04	Ranjit K. Chandra	Nutritional supplement for the elderly
US5372852A (en) *	1992-11-25	1994-12-13	Tektronix, Inc.	Indirect printing process for applying selective phase change ink compositions to substrates
US5502041A (en)	1992-12-11	1996-03-26	The Center For Innovative Technology	Potent inhibitor of HIV reverse transcriptase
GB9304746D0 (en)	1993-03-09	1993-04-28	Scotia Holdings Plc	Treatment of viral infections
US5472952A (en)	1993-03-18	1995-12-05	Bristol-Myers Squibb Company	Partially hydrolyzed pectin in nutritional compositions
US5405637A (en)	1993-06-30	1995-04-11	Bristol-Myers Squibb Company	Milk protein partial hydrolysate and infant formula containing same
GB9318611D0 (en)	1993-09-08	1993-10-27	Sandoz Nutrition Ltd	Improvements in or relating to organic compounds
JP3310738B2 (ja)	1993-11-10	2002-08-05	株式会社ロッテ	低カロリーチョコレート
DE4404877C1 (de)	1994-02-17	1995-03-02	Ksk Industrielackierungen Gmbh	Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
WO1995026646A1 (en)	1994-04-01	1995-10-12	Abbott Laboratories	Nutritional product for treatment of ulcerative colitis and use thereof
US5952314A (en)	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
US5444054A (en) *	1994-04-01	1995-08-22	Abbott Labatories	Method of treating ulcerative colitis
DE69520528T2 (de)	1994-06-14	2001-09-27	Raffinerie Tirlemontoise, S.A.	Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
JP3419897B2 (ja) *	1994-07-22	2003-06-23	明治乳業株式会社	低アレルギー性調製乳
NL9401644A (nl)	1994-10-06	1996-05-01	Friesland Brands Bv	Voedingsmiddel voor zwangere en lacterende vrouwen
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Bacteria and immunoglobulin-containing composition for human gastrointestinal health
EP0711503A3 (en)	1994-11-14	1997-11-26	Scotia Holdings Plc	Milk fortified with GLA and/or DGLA
JPH08151328A (ja)	1994-11-28	1996-06-11	Fuji Ratetsukusu Kk	エイズ感染防止潤滑剤
US5733579A (en)	1995-04-05	1998-03-31	Abbott Laboratories	Oral rehydration solution containing indigestible oligosaccharides
US6099871A (en)	1995-06-01	2000-08-08	Bristol-Myers Squibb Company	Anti-regurgitation infant formula
US20020016289A1 (en)	1995-06-01	2002-02-07	Orla M. Conneely	Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5827526A (en) *	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE69506095T2 (de)	1995-08-04	1999-06-24	Naamloze Vennootschap Nutricia, Zoetermeer	Diätfasern enthaltende Nahrungszusammensetzung
JPH0965855A (ja)	1995-08-28	1997-03-11	Otsuka Shokuhin Kk	低カロリー整腸食品素材
MY115050A (en)	1995-10-16	2003-03-31	Mead Johnson Nutrition Co	Diabetic nutritional product having controlled absorption of carbohydrate
AUPN881396A0 (en)	1996-03-20	1996-04-18	Arnott's Biscuits Limited	Enhancement of microbial colonization of the gastrointestinal tract
CA2205773A1 (en)	1996-06-21	1997-12-21	Kraft Foods, Inc.	Creamy, thick, hot beverage foam
ES2184847T5 (es)	1996-07-31	2007-03-01	"RAFFINERIE TIRLEMONTOISE", SOCIETE ANONYME	Polvos lacticos que contienen fructano y/o polidextrosa, procedimiento para su preparacion y su uso.
FR2752381B1 (fr) *	1996-08-13	1998-11-06	Pierre Moreau	Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
JP3792309B2 (ja)	1996-08-30	2006-07-05	サントリー株式会社	不飽和脂肪酸含有油脂の製造方法
GB9619660D0 (en)	1996-09-20	1996-11-06	Scient Hospital Suppl Int Ltd	Prevention of gastrointestinal damage
JPH10108647A (ja)	1996-10-08	1998-04-28	Meiji Seika Kaisha Ltd	胃切除術後患者用ミネラル補給材
DE69719539D1 (de)	1996-11-05	2003-04-10	Wisconsin Alumni Res Found	Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer-lymphozyten
JP4008974B2 (ja)	1996-12-12	2007-11-14	森永乳業株式会社	ビフィズス菌増殖促進組成物及びその用途
AUPO430496A0 (en)	1996-12-19	1997-01-23	Arnott's Biscuits Limited	Prebiotics and probiotics
DE19701382A1 (de)	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
EP1039892B1 (en) *	1997-02-21	2004-04-28	Abbott Laboratories	Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
US5840361A (en)	1997-04-09	1998-11-24	Beech-Nut Nutrition Corporation	Fructan-containing baby food compositions and methods therefor
NZ337459A (en)	1997-04-11	2000-07-28	Abbott Lab	Nucleic acid construct in plants and dietary supplement
NL1005809C2 (nl)	1997-04-14	1998-10-19	Dsm Nv	Poederverfbindmiddelsamenstelling.
US5846569A (en)	1997-06-20	1998-12-08	Creative Labs, Inc.	Colostrum supplement
US6051260A (en) *	1998-04-07	2000-04-18	Healthcomm International, Inc.	Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
GB9808579D0 (en)	1998-04-22	1998-06-24	Novartis Nutrition Ag	Improvements in or relating to organic compounds
EP0958825A1 (en)	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
FR2781673B1 (fr)	1998-07-28	2001-09-28	Univ Picardie	Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
US6231889B1 (en)	1998-09-21	2001-05-15	Chronorx, Llc	Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en)	1998-10-19	2004-09-21	New Nordic Danmark Aps	Composition comprising extensin and, optionally, pectic polysaccharides
CA2360646C (en)	1999-01-28	2009-08-04	Societe Des Produits Nestle S.A.	Aromatised soluble creamer powder
EP1074181A1 (en)	1999-08-03	2001-02-07	Societe Des Produits Nestle S.A.	Foaming creamer ingredient and powders containing it
DE19940011B4 (de)	1999-08-24	2009-04-02	Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte	Alginataufbereitung und deren Verwendung
US6737089B2 (en)	1999-08-27	2004-05-18	Morinda, Inc.	Morinda citrifolia (Noni) enhanced animal food product
EP1062873A1 (en)	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10006989A1 (de)	2000-02-16	2001-08-23	Nutricia Nv	Antiadhäsive Kohlenhydratmischung
US6846501B2 (en)	2000-04-12	2005-01-25	Mid-America Commercialization Corporation	Traditional snacks having balanced nutritional profiles
US6495599B2 (en) *	2000-04-13	2002-12-17	Abbott Laboratories	Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
EP1155627A1 (en)	2000-05-18	2001-11-21	Belovo Eggs & Egg Products	Eggs with balanced lipid composition
DE10027050A1 (de)	2000-06-02	2001-12-13	Karim Balan	Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en)	2000-08-11	2002-07-30	Global Health Sciences, Inc.	Low-carbohydrate high-protein creamer powder
US6592863B2 (en) *	2000-08-22	2003-07-15	Nestec S.A.	Nutritional composition
EP1321527A4 (en)	2000-08-30	2004-08-11	Amano Enzyme Inc	METHOD FOR INCREASING THE YIELD OF ALPHA-GALACTOSYL-CONTAINING OLIGOSACCHARIDES AND ANTI-CANDIDA COMPOSITIONS
CN1111541C (zh)	2000-09-15	2003-06-18	青岛海洋大学	一种聚甘露糖醛酸硫酸盐
US20050238655A1 (en)	2004-01-06	2005-10-27	Paul Stamets	Antiviral activity from medicinal mushrooms
AU2002243267A1 (en)	2000-10-27	2002-06-24	Mannatech, Inc.	Dietary supplement compositions
EP1208792A1 (de) *	2000-11-17	2002-05-29	Haag-Streit Ag	Vorrichtung und Verfahren zur Untersuchung und/oder Behandlung eines Auges
DE10057976B4 (de)	2000-11-22	2005-02-03	Südzucker AG Mannheim/Ochsenfurt	Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en)	2000-12-13	2003-01-28	Novartis Nutrition Ag	Infant formula with free amino acids and nucleotides
FI109602B (fi) *	2001-01-25	2002-09-13	Valio Oy	Probioottiyhdistelmä
EP1355544A2 (en)	2001-01-30	2003-10-29	Unilever N.V.	Food product comprising protein coated gas microbubbles
EP1228694A1 (en)	2001-02-02	2002-08-07	Societe Des Produits Nestle S.A.	Aromatizing agent
US20030165604A1 (en)	2001-02-15	2003-09-04	Kazufumi Tsubaki	Products containing $g(b)-glucan
EP1243273A1 (en)	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
JP3814494B2 (ja) *	2001-04-27	2006-08-30	松下電器産業株式会社	色管理装置及び色管理システム
DE10136260B4 (de)	2001-07-25	2004-07-08	Südzucker AG Mannheim/Ochsenfurt	Inulin in Geliermittelzusammensetzungen
NL1018832C2 (nl)	2001-08-27	2003-03-03	Friesland Brands Bv	Melkvervangend voedingsmiddel omvattend johannesbroodpitmeel.
JP2003146887A (ja)	2001-11-07	2003-05-21	Gotoo Corporation:Kk	Ｎｋ細胞活性化作用を有する製剤および飲食品
WO2003093322A2 (en)	2002-04-30	2003-11-13	The Population Council, Inc.	Carrageenan based antimicrobial compositions
US6623954B1 (en)	2002-05-28	2003-09-23	Neose Technologies, Inc.	Process for removal of phosphorous from a dairy stream
BRPI0311909A8 (pt)	2002-06-19	2018-02-06	Nutricia Nv	Métodos para a manufatura de uma composição, e para aumentar a capacidade de metilação de um indivíduo, e, composição farmacêutica ou nutricional
EP1374878A1 (en)	2002-06-20	2004-01-02	N.V. Nutricia	Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
DK1538924T3 (da)	2002-08-30	2008-02-04	Campina Bv	Skummende ingrediens og produkter indeholdende ingrediensen
US20040087490A1 (en)	2002-09-20	2004-05-06	Troup John P.	Nutritional compositions
AU2003299034A1 (en)	2002-09-20	2004-04-08	Griscom Bettle Iii	Transdermal compositions
US6974841B1 (en)	2002-09-27	2005-12-13	Rapisarda Family Irrevocable Trust	Pet anti-aging wellness supplement
GB0229015D0 (en)	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
US20040219188A1 (en) *	2003-05-02	2004-11-04	Comer Gail M.	Composition and methods for nutritional management of patients with hepatic disease
EP1638415B1 (en)	2003-06-23	2010-12-15	Nestec S.A.	Infant or follow-on formula
CN1863463B (zh)	2003-06-23	2011-05-04	雀巢技术公司	用于促进肠道屏障成熟的营养组合物
EP1491570A1 (en)	2003-06-25	2004-12-29	DSM IP Assets B.V.	Powder coating composition for low temperature cure
AU2003904192A0 (en)	2003-08-11	2003-08-21	Adelaide Research and Innovaiton Pty Ltd	Method for inhibiting bacterial colonisation
PL1675481T3 (pl)	2003-10-24	2009-03-31	Nutricia Nv	Kompozycja synbiotyczna dla niemowląt
SG152271A1 (en)	2003-10-24	2009-05-29	Nutricia Nv	Immunemodulating oligosaccharides
FR2866203B1 (fr)	2004-02-13	2006-12-08	Roquette Freres	Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en)	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
EP1723951A1 (en)	2005-04-21	2006-11-22	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
EP1721611A1 (en)	2005-04-21	2006-11-15	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
CA2570208A1 (en)	2004-06-22	2005-12-29	N.V. Nutricia	Improvement of barrier integrity in hiv patients
EP1778857A4 (en)	2004-07-07	2007-09-26	Gen Hospital Corp	Direct activation of atiii in whole blood and plasma
WO2006007676A1 (en)	2004-07-21	2006-01-26	Amazônia Fitomedicamentos Ltda.	Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
JP4653465B2 (ja)	2004-10-25	2011-03-16	泰信小林	ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物
ATE471665T1 (de)	2005-04-21	2010-07-15	Nutricia Nv	Nahrungsergänzungsmittel für hiv-patienten
EP1916908A1 (en)	2005-07-27	2008-05-07	Cantabria Group LCC	Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
MX2008001173A (es)	2005-07-29	2008-03-18	Alcon Refractive Horizons Inc	Sistema de colocacion lateral de dispositivo oftalmico y metodos asociados.
US20070231449A1 (en)	2006-03-30	2007-10-04	Nutracea	Non-starchy rice bran polysaccharides
WO2009096772A1 (en)	2008-02-01	2009-08-06	N.V. Nutricia	Composition for stimulating natural killer cell activity
US9281963B2 (en) *	2008-12-23	2016-03-08	Persistent Systems Limited	Method and system for email search

2004
- 2004-06-06 US US11/571,122 patent/US8252769B2/en active Active
- 2004-06-22 DE DE602004020813T patent/DE602004020813D1/de not_active Expired - Lifetime
- 2004-06-22 PL PL09158304T patent/PL2100520T3/pl unknown
- 2004-06-22 CN CN200480043417A patent/CN100589712C/zh not_active Expired - Lifetime
- 2004-06-22 ES ES04748674T patent/ES2285484T3/es not_active Expired - Lifetime
- 2004-06-22 PT PT91583047T patent/PT2100520E/pt unknown
- 2004-06-22 EP EP07108969A patent/EP1815755B1/en not_active Revoked
- 2004-06-22 DE DE602004006765T patent/DE602004006765T2/de not_active Expired - Lifetime
- 2004-06-22 ES ES07108969T patent/ES2323988T3/es not_active Expired - Lifetime
- 2004-06-22 AU AU2004320743A patent/AU2004320743B2/en not_active Expired
- 2004-06-22 AT AT04748674T patent/ATE363213T1/de active
- 2004-06-22 JP JP2007517980A patent/JP4903695B2/ja not_active Expired - Lifetime
- 2004-06-22 PT PT04748674T patent/PT1672987E/pt unknown
- 2004-06-22 AT AT07108969T patent/ATE429155T1/de active
- 2004-06-22 NZ NZ552166A patent/NZ552166A/en not_active IP Right Cessation
- 2004-06-22 BR BRPI0418921-3A patent/BRPI0418921A/pt not_active Application Discontinuation
- 2004-06-22 RU RU2007102085/10A patent/RU2402240C2/ru active
- 2004-06-22 DK DK09158304.7T patent/DK2100520T3/da active
- 2004-06-22 WO PCT/NL2004/000444 patent/WO2005122790A1/en not_active Ceased
- 2004-06-22 SI SI200431140T patent/SI1815755T1/sl unknown
- 2004-06-22 PL PL07108969T patent/PL1815755T3/pl unknown
- 2004-06-22 UA UAA200613595A patent/UA81875C2/uk unknown
- 2004-06-22 EP EP04748674A patent/EP1672987B1/en not_active Revoked
- 2004-06-22 PT PT07108969T patent/PT1815755E/pt unknown
- 2004-06-22 DK DK04748674T patent/DK1672987T3/da active
- 2004-06-22 CA CA2570205A patent/CA2570205C/en not_active Expired - Lifetime
- 2004-06-22 DK DK07108969T patent/DK1815755T3/da active
- 2004-06-22 ES ES09158304T patent/ES2431363T3/es not_active Expired - Lifetime
- 2004-06-22 PL PL04748674T patent/PL1672987T3/pl unknown
- 2004-06-22 EP EP09158304.7A patent/EP2100520B1/en not_active Revoked
2005
- 2005-06-22 ZA ZA200700138A patent/ZA200700138B/en unknown
2009
- 2009-07-14 CY CY20091100740T patent/CY1109224T1/el unknown
2012
- 2012-08-24 US US13/594,147 patent/US9084433B2/en not_active Expired - Lifetime
2015
- 2015-06-15 US US14/739,850 patent/US10499676B2/en not_active Expired - Lifetime
2019
- 2019-12-07 US US16/706,725 patent/US11076623B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1815755B1 (en)	2009-04-22
CA2570205C (en)	2012-10-30
SI1815755T1 (sl)	2009-08-31
EP1672987B1 (en)	2007-05-30
US10499676B2 (en)	2019-12-10
DE602004020813D1 (de)	2009-06-04
CA2570205A1 (en)	2005-12-29
DK1815755T3 (da)	2009-06-02
US20080064656A1 (en)	2008-03-13
ZA200700138B (en)	2008-05-28
EP2100520B1 (en)	2013-07-31
CN1997290A (zh)	2007-07-11
PT2100520E (pt)	2013-11-06
US20160073669A1 (en)	2016-03-17
DE602004006765T2 (de)	2008-01-24
AU2004320743A1 (en)	2005-12-29
EP2100520A3 (en)	2009-11-25
US20130053340A1 (en)	2013-02-28
DE602004006765D1 (de)	2007-07-12
AU2004320743B2 (en)	2010-04-08
EP1672987A1 (en)	2006-06-28
UA81875C2 (uk)	2008-02-11
ES2285484T3 (es)	2007-11-16
ES2323988T3 (es)	2009-07-28
US8252769B2 (en)	2012-08-28
US20170042197A9 (en)	2017-02-16
JP4903695B2 (ja)	2012-03-28
PL2100520T3 (pl)	2014-01-31
ATE429155T1 (de)	2009-05-15
EP2100520A2 (en)	2009-09-16
PL1672987T3 (pl)	2007-10-31
JP2008503568A (ja)	2008-02-07
PT1815755E (pt)	2009-09-03
EP1815755A1 (en)	2007-08-08
CN100589712C (zh)	2010-02-17
US9084433B2 (en)	2015-07-21
BRPI0418921A (pt)	2007-11-27
WO2005122790A1 (en)	2005-12-29
CY1109224T1 (el)	2014-07-02
DK2100520T3 (da)	2013-10-28
RU2007102085A (ru)	2008-07-27
ES2431363T3 (es)	2013-11-26
US11076623B2 (en)	2021-08-03
NZ552166A (en)	2010-05-28
ATE363213T1 (de)	2007-06-15
US20200281241A1 (en)	2020-09-10
RU2402240C2 (ru)	2010-10-27
PT1672987E (pt)	2007-09-11
DK1672987T3 (da)	2007-10-01

Publication	Publication Date	Title
PT1815755E (pt)	2009-09-03	Melhoria da integridade da barreira intestinal
WO2007058538A3 (en)	2008-06-12	Composition with docosapentaenoic acid
NO20065915L (no)	2007-03-22	Forbedring av barriereintegritet i HIV-pasienter
NZ600167A (en)	2014-06-27	Concentrated therapeutic phospholipid compositions
MX338247B (es)	2016-04-07	Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
WO2008018043A3 (en)	2008-10-16	Methods of improving bone health and muscle health
SG10201400685SA (en)	2015-01-29	Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
NZ599067A (en)	2014-04-30	Fatty acid niacin conjugates and their uses
WO2004004638A3 (en)	2004-03-25	Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
WO2004112776A3 (en)	2005-03-31	Inflammatory disease treatment
WO2008147562A3 (en)	2009-07-16	Dietary formulations and methods for treatment of inflammation and other disorders
CY1105119T1 (el)	2009-11-04	Χρηση πολυακορεστων λιπαρων οξεων για την πρωτογενη προληψη σοβαρων καρδιαγγειακων επεισοδιων
WO2006078463A3 (en)	2007-05-31	Method for treating cardiovascular disease
WO2009028457A1 (ja)	2009-03-05	非アルコール性脂肪肝炎治療薬
PL2164520T3 (pl)	2020-04-30	Cyklodekstryny do podawania kwasów tłuszczowych w tabletkach
UA88030C2 (ru)	2009-09-10	Композиция, которая содержит омега-3-жирные кислоты и омега-6-жирные кислоты, для лечения синдрома сухого глаза
MXPA06003678A (es)	2006-06-05	Metodos y estuches para mejorar la capacidad de aprender en un cachorro de perro o cachorro de gato.
WO2010083279A3 (en)	2010-11-18	Methods for treating disorders associated with hyperlipidemia in a mammal
UA41549U (ru)	2009-05-25	Способ коррекции атеросклеротического поражения сосудов у больных ревматоидным артритом
WO2009114090A3 (en)	2009-12-10	Method for inhibiting the build-up of arterial plaque by administering fullerenes
UA27389U (en)	2007-10-25	Method for treating refractory forms of non-hodgkin lymphoma
UA74544U (ru)	2012-11-12	Способ лечения и профилактики хронического генерализованного пародонтита